(Q34665871)

3 August 2017

1 reference

title

Modafinil: a review of neurochemical actions and effects on cognition (English)

1 reference

3 August 2017

1 reference

Michael J Minzenberg

1

1 reference

3 August 2017

Cameron S Carter

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

22 August 2007

1 reference

3 August 2017

Neuropsychopharmacology

1 reference

3 August 2017

33

1 reference

3 August 2017

1477-1502

1 reference

3 August 2017

7

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301534

3 August 2017

0 references

cites work

Alpha 2-adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

The role of histamine and the tuberomamillary nucleus in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

Longer auditory and visual P300 latencies in patients with narcolepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

Single-dose pharmacokinetics of modafinil and methylphenidate given alone or in combination in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

Comparison of the single-dose pharmacokinetics and tolerability of modafinil and dextroamphetamine administered alone or in combination in healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

A stereological study on the neuroprotective actions of acute Modafinil treatment on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigral lesions of the male black mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effect of modafinil and amphetamine on the rat catecholaminergic neuron activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil prevents glutamate cytotoxicity in cultured cortical neurons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Cellular and subcellular sites for noradrenergic action in the monkey dorsolateral prefrontal cortex as revealed by the immunocytochemical localization of noradrenergic receptors and axons.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Adrenergic targets for the treatment of cognitive deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Postsynaptic alpha-2 receptor stimulation improves memory in aged monkeys: Indirect effects of yohimbine versus direct effects of clonidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Alpha-2 adrenergic agonists decrease distractibility in aged monkeys performing the delayed response task

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Neuromodulation and cognitive performance: recent studies of noradrenergic locus ceruleus neurons in behaving monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Conditioned responses of monkey locus coeruleus neurons anticipate acquisition of discriminative behavior in a vigilance task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Role of the locus coeruleus in emotional activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A Systematic Review of Modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of modafinil on cognitive and meta-cognitive performance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Phasic not tonic pupillary responses vary with auditory vigilance performance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

First evidence of a delay-dependent working memory-enhancing effect of modafinil in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Improvement of learning processes following chronic systemic administration of modafinil in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Enhancement of learning processes following an acute modafinil injection in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Use of modafinil in the treatment of narcolepsy: a long term follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A Comparison of Once-Daily and Divided Doses of Modafinil in Children With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Acetylcholine, histamine, and cognition: two sides of the same coin.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Cognition and control in schizophrenia: a computational model of dopamine and prefrontal function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopamine and norepinephrine innervated cells in the rat prefrontal cortex: pharmacological differentiation using microiontophoretic techniques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha 2-adrenergic agonist clonidine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Immunocytochemical localization of the dopamine transporter in human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopamine activates noradrenergic receptors in the preoptic area.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopaminergic modulation of behavioral states in mesopontine tegmentum: a reverse microdialysis study in freely moving cats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil for excessive sleepiness associated with shift-work sleep disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A double-blind, placebo-controlled trial of modafinil for cocaine dependence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Cognitive performance during sustained wakefulness: A low dose of caffeine is equally effective as modafinil in alleviating the nocturnal decline.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Lack of pre-synaptic dopaminergic involvement in modafinil activity in anaesthetized mice: in vivo voltammetry studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A prospective trial of modafinil as an adjunctive treatment of major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Influence of modafinil on somatosensory input processing in the human brain-stem.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil-associated clozapine toxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Alpha2-adrenoceptor mediated co-release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex induced by clozapine, the prototype atypical antipsychotic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dissociation in prefrontal cortex of affective and attentional shifts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Pharmacodynamic effects on alertness of single doses of armodafinil in healthy subjects during a nocturnal period of acute sleep loss

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The computational role of dopamine D1 receptors in working memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A possible α-adrenergic mechanism for drug (CRL 40028)-induced hyperactivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Central alpha 1-adrenergic stimulation in relation to the behaviour stimulating effect of modafinil; studies with experimental animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Differential effects of modafinil and methylphenidate on stop-signal reaction time task performance in the rat, and interactions with the dopamine receptor antagonist cis-flupenthixol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Differential patterns of regional c-Fos induction in the rat brain by amphetamine and the novel wakefulness-promoting agent modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil and unconstrained motor activity in schizophrenia: double-blind crossover placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil does not affect serotonin efflux from rat frontal cortex synaptosomes: comparison with known serotonergic drugs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: possible involvement of the serotonergic 5-HT3 receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effect of modafinil on cerebral blood flow of anaesthetised rats. Comparison with amphetamine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Inhibitory effects of trace amines on rat midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil attenuates disruptions in cognitive performance during simulated night-shift work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Steady-state pharmacokinetics and tolerability of modafinil given alone or in combination with methylphenidate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Steady-state pharmacokinetics and tolerability of modafinil administered alone or in combination with dextroamphetamine in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Awakening properties of modafinil: effect on nocturnal activity in monkeys(Macaca mulatta) after acute and repeated administration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Impact of modafinil on prefrontal executive function in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil increases histamine release in the anterior hypothalamus of rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

An evaluation of the abuse potential of modafinil using methylphenidate as a reference.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Loss of autoreceptor functions in mice lacking the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil inhibits rat midbrain dopaminergic neurons through D2-like receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of mammillary bodies and mediodorsal thalamic lesions on the acquisition and retention of a learning set in mice: paradoxical effect of the intersession interval.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Noradrenergic innervation of monkey prefrontal cortex: a dopamine-beta-hydroxylase immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Role of catecholamines in the modafinil and amphetamine induced wakefulness, a comparative pharmacological study in the cat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil and cocaine interactions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

5-HT2A receptor or alpha1-adrenoceptor activation induces excitatory postsynaptic currents in layer V pyramidal cells of the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Differential involvement of anterior and posterior cingulate cortices in spatial discriminative learning in a T-maze in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil binds to the dopamine uptake carrier site with low affinity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Primate trace amine receptor 1 modulation by the dopamine transporter.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Long-term efficacy and safety of modafinil (PROVIGIL((R))) for the treatment of excessive daytime sleepiness associated with narcolepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil improves attention, inhibitory control, and reaction time in healthy, middle-aged rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of modafinil on working memory processes in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil enhances extracellular levels of dopamine in the nucleus accumbens and increases wakefulness in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

P300 and treatment effect of modafinil on fatigue in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Is psychosis exacerbated by modafinil?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The functional anatomy of verbal initiation and suppression using the Hayling Test

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The role of the dorsolateral prefrontal cortex: evidence from the effects of contextual constraint in a sentence completion task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The hypocretin/orexin system in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A case of premature ventricular contractions with modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Central histaminergic system and cognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of the vigilance promoting drug modafinil on the synthesis of GABA and glutamate in slices of rat hypothalamus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil-induced modulation of working memory and plasma corticosterone in chronically-stressed mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of a vigilance-enhancing drug, modafinil, on rat brain metabolism: a 2D COSY 1H-NMR study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Cognitive effects of modafinil in student volunteers may depend on IQ.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil affects mood, but not cognitive function, in healthy young volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Does modafinil enhance cognitive performance in young volunteers who are not sleep-deprived?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil-induced irritability and aggression? A report of 2 bipolar patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Contrasting effects of response uncertainty on the task-evoked pupillary response and reaction time

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Clinical pharmacokinetic profile of modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effect of modafinil at steady state on the single-dose pharmacokinetic profile of warfarin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil in children with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Visual P300 latency predicts treatment response to modafinil in patients with narcolepsy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Attenuation of delay-period activity of monkey prefrontal neurons by an alpha2-adrenergic antagonist during an oculomotor delayed-response task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Hypothalamic arousal regions are activated during modafinil-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of modafinil on wakefulness and executive function in patients with narcolepsy experiencing late-day sleepiness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Determination of modafinil in plasma and urine by reversed phase high-performance liquid-chromatography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The principal features and mechanisms of dopamine modulation in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The stimulant effect of modafinil on wakefulness is not associated with an increase in anxiety in mice. A comparison with dexamphetamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Single-unit and polygraphic recordings associated with systemic or local pharmacology: a multi-purpose stereotaxic approach for the awake, anaesthetic-free, and head-restrained rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil modulates anterior cingulate function in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Role of brain alpha 1B-adrenoceptors in modafinil-induced behavioral activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Stress-induced subsensitivity to modafinil and its prevention by corticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A randomized, double-blind, crossover trial of modafinil on mood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

6-hydroxy-dopamine treatment counteracts the reduction of cortical GABA release produced by the vigilance promoting drug modafinil in the awake freely moving guinea-pig.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Inhibitory effects of the psychoactive drug modafinil on gamma-aminobutyric acid outflow from the cerebral cortex of the awake freely moving guinea-pig. Possible involvement of 5-hydroxytryptamine mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil and cortical gamma-aminobutyric acid outflow. Modulation by 5-hydroxytryptamine neurotoxins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Topographical distribution of dopaminergic innervation and dopaminergic receptors of the anterior cerebral cortex of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil activates cortical and subcortical sites in the sleep-deprived state.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of modafinil-induced wakefulness on glutamine synthetase regulation in the rat brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Awakening properties of modafinil without paradoxical sleep rebound: comparative study with amphetamine in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Detection of modafinil in human urine by gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Cognitive enhancing effects of modafinil in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The role of locus coeruleus in the regulation of cognitive performance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Mania in a boy treated with modafinil for narcolepsy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil improves alertness, vigilance, and executive function during simulated night shifts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil facilitates performance on a delayed nonmatching to position swim task in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Effects of modafinil on cognitive performance and alertness during sleep deprivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Under the curve: critical issues for elucidating D1 receptor function in working memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Characterization of the dopaminergic innervation of the primate frontal cortex using a dopamine-specific antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil more effectively induces wakefulness in orexin-null mice than in wild-type littermates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Armodafinil, the R-enantiomer of modafinil: wake-promoting effects and pharmacokinetic profile in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Dopaminergic role in stimulant-induced wakefulness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

A double-blind, placebo-controlled, ascending-dose evaluation of the pharmacokinetics and tolerability of modafinil tablets in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Trace amine-associated receptor 1 is a modulator of the dopamine transporter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Potency of catecholamines and other L-tyrosine derivatives at the cloned mouse adrenergic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301534

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301534

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference